“23. EFFICACY, SAFETY AND ECONOMIC EVALUATION OF SUBCUTANEOUS RITUXIMAB VERSUS INTRAVENOUS RITUXIMAB IN PATIENTS WITH NON-HODGKIN LYMPHOMA: A SYSTEMATIC REVIEW”. Vietnam Journal of Community Medicine 65, no. CĐ 12 - Bệnh viện Thủ Đức (December 12, 2024). Accessed September 9, 2026. https://tapchiyhcd.vn/index.php/yhcd/article/view/1833.